Reconstituting SLU-PP-332 with DMSO: a documented run with photos

SLU-PP-332 does not dissolve in bacteriostatic water, because it is a lipophilic small molecule rather than a peptide. The run documented here dissolves the solid in a small volume of dimethyl sulfoxide (DMSO) first and then adds that DMSO solution slowly to bacteriostatic water, never the reverse. Each step is shown in photos and short videos, with the solubility chemistry that explains it.

Not a peptide, and that is the whole point

The name keeps peptide company, but SLU-PP-332 is a synthetic small molecule that the preclinical literature describes as a pan-agonist at the estrogen-related receptors (ERRα, ERRβ, ERRγ) and characterises as a medicinal-chemistry tool compound; human data are not published. The identifier follows a laboratory series, not an amino-acid sequence. That is why the habits from peptide reconstitution fail: a lyophilised peptide is an amorphous cake of ionisable side chains that wants water, while a lipophilic solid has a crystal lattice to break and nothing for water to organise around.

Like dissolves like does real work here. Dissolving something in water means opening its hydrogen-bonded network and re-forming it around the solute; polar and ionic solutes pay that energetic bill with charge-dipole interactions and hydrogen bonds, and a non-polar molecule has nothing to pay with. pH is no lever either, since a molecule without ionisable groups has no isoelectric point to move away from.

Bacteriostatic water changes nothing about that: its benzyl alcohol is a preservative at roughly 0.9%, far below a cosolvent concentration, so in solvent terms it is sterile water. Patience and ultrasound act on kinetics – agglomerates, boundary layers, a dissolution that would finish anyway. Neither shifts equilibrium solubility, so the haze after a spell in an ultrasonic bath is a suspension that settles back out.

Why the order matters

Dimethyl sulfoxide is a polar aprotic solvent: large dipole moment, a sulfinyl oxygen that accepts hydrogen bonds unusually well, no acidic hydrogen to donate. It therefore solvates polar and non-polar regions of the same molecule, which is why it is a default vehicle for poorly water-soluble compounds. Ethanol, propylene glycol and polyethylene glycol 400 serve the same end in marketed parenteral products, lowering the dielectric constant so a non-polar solute is less unwelcome. Cyclodextrins reach a similar result by a different route, enclosing the non-polar part of a molecule in a complex.

A cosolvent solution hands the problem back once water arrives. The logarithm of solubility falls roughly in a straight line as the cosolvent fraction drops – the classical cosolvency model – and where the dissolved amount exceeds what the new mixture can hold, the compound leaves solution. Formulators call it solvent-shift precipitation.

The same model explains why the direction of mixing decides the outcome. Wherever a concentrate and water first meet, the local composition is momentarily far poorer in cosolvent than the bulk, so the solubility limit is exceeded at that boundary long before it is exceeded on average. When a small volume of DMSO solution runs slowly into a larger volume of water that is kept moving, each pocket of that boundary is small and is diluted within moments. When water is added to the DMSO solution instead, the entire solution is walked step by step through every intermediate composition, and the compound can crystallise on the way. Once a crystalline phase has formed, redissolution is slow and often incomplete. That is the reasoning behind the order in steps 5 to 9 below.

What was on the bench

The photo shows what the author used for this run:

• a vial containing 5 mg SLU-PP-332 as a white powder,
• an empty sterile 3 mL glass vial,
• 2.5 mL bacteriostatic water, in its own vial,
• 0.5 mL DMSO of Ph. Eur. grade, drawn from a larger bottle,
• two 1 mL insulin syringes with a fixed needle,
• alcohol swabs.

The volumes describe this particular run and follow from the vial sizes on the bench. The resulting concentration is simply the mass in the vial divided by the total final volume, cosolvent included, as set out further down.

The documented run, step by step

Step 1: the caps come off

The coloured plastic flip-off caps came off the SLU-PP-332 vial and the bacteriostatic water vial; the empty vial had arrived without one. After that, the rubber stopper under its metal crimp was exposed on all three vials.

Step 2: the stoppers are wiped

The author wiped the rubber stopper of each of the three vials with an alcohol swab. Aseptic-technique standards such as USP General Chapter 797 treat the closure as the critical surface before every entry, which is also why the author wiped a stopper again later whenever it had been touched.

Step 3: 0.5 mL DMSO is drawn up

With the first 1 mL insulin syringe, the author drew 0.5 mL DMSO from the bottle. Only the needle went into the liquid, not the plastic hub or barrel. DMSO is an aggressive solvent towards many plastics and surfaces, so the less plastic it touches, the less material it can pick up.

The result was 0.5 mL of DMSO in the syringe.

Step 4: DMSO goes into the SLU-PP-332 vial

Plastic syringes carry a thin lubricating coating on the inside of the barrel, and DMSO can dissolve part of it. The author therefore worked briskly without hurrying: the DMSO was transferred slowly into the SLU-PP-332 vial, with the vial turned slightly during the transfer.

Afterwards the author kept turning the vial to speed up dissolution. In neat DMSO the solid dissolves readily; this is the step in which the solvent does its real work.

Step 5: bacteriostatic water goes into the empty vial

The DMSO solution is later added to the water and not the other way round, so the water first needed a vial of its own. With the second syringe, the author transferred bacteriostatic water from its original vial into the empty sterile vial.

Where a stopper had been touched in between, the author wiped it again. With 1 mL syringes, 2.5 mL took three transfers: two full syringes of 1 mL and one of 0.5 mL.

Step 6: waiting until the solution is clear

The author waited until the SLU-PP-332 had dissolved completely in the DMSO and the solution was as clear as water. Where it was not yet clear, the vial was swirled, not shaken. Shaking introduces air and foam and adds nothing that swirling does not already do for a small molecule in a good solvent.

The result was two clear vials: 2.5 mL bacteriostatic water, and 0.5 mL DMSO with the SLU-PP-332 dissolved in it.

Step 7: the DMSO solution is drawn up

The author pierced the stopper of the SLU-PP-332 vial with the second syringe and drew up the solution.

The syringe then held the 0.5 mL of DMSO solution, which is the 50-unit mark on a U-100 insulin syringe.

Step 8: the DMSO solution runs into the water

The author pierced the stopper of the vial with the bacteriostatic water.

This is the step the cosolvency model is about. The author let the DMSO solution run slowly along the inside of the glass wall into the bacteriostatic water, instead of shooting it into the middle of the liquid. Running down the wall spreads the incoming solution into a thin film that mixes gradually.

For the rest of the transfer, as the photos show, the author held the vial on its side and turned it, so that the incoming solution never collected in a still pocket of water. Without that movement, SLU-PP-332 can precipitate at the boundary between the two liquids, and precipitated material cannot reliably be brought back into solution.

Directly afterwards the liquid was clear but showed streaks. These schlieren are zones of different refractive index, where DMSO-rich and water-rich liquid have not yet mixed. They are not solid material.

Step 9: swirling until the streaks are gone

The author swirled and turned the vial until no streaks were left and the mixture looked uniform. A streak-free, clear liquid is the visual sign that DMSO and water have mixed completely.

Step 10: disposal

Both syringes and the empty vials went into a sharps container. A puncture-resistant container is the conventional disposal route for needles, because a used needle in household waste is a hazard for whoever handles the bag next.

Streaks, haze and sediment

With a peptide, cloudiness usually means something failed. In a cosolvent-water mixture near its solubility limit it can also be a phase phenomenon: scattering from very small particles, or a transient supersaturated state. The three things that can be seen in the vial are therefore different in kind:

• Streaks are a mixing phenomenon in an otherwise clear liquid, and they disappear with swirling.
• Haze is light scattered by very small particles and suggests the compound is at or beyond its solubility limit in that mixture.
• Sediment or floating solid is compound out of solution; redissolution of a crystallised phase is slow and often incomplete.

The run above ended at the first of these, with streaks that swirled away. Haze or sediment would have meant that the solvent shift had outrun the mixing.

What cold does to the mixture

Temperature moves the solubility line, since the solubility of most organic solids falls as a mixture cools. Freezing is harsher: neat DMSO solidifies near 18.5 °C, so a solution in pure DMSO is solid in a refrigerator, and ice formation in a water mixture concentrates whatever remains in the shrinking liquid phase, which is why freeze-thaw cycling crashes such mixtures for good. Cold, dark and unfrozen is what the handling literature describes for reconstituted material. A mixture that has turned cloudy in the refrigerator has left solution in the same way as one that was mixed in the wrong order.

DMSO grade, sterility and the author's reasoning

DMSO is not an inert diluent. It crosses skin and membranes readily and carries dissolved solutes with it, and in concentrated form it is irritant on contact with tissue, one reason parenteral formulations keep cosolvent fractions low. Monographs for dimethyl sulfoxide could be found in both USP-NF and Ph. Eur., and they set limits for purity and water content; technical grades fall outside those monographs.

The author could not find sterile DMSO outside a pharmaceutical setting and used Ph. Eur. grade. A PTFE syringe filter would have made sterile filtration possible, as the filtering page describes; PTFE is the membrane specified for solvents, while some hydrophilic membranes used for aqueous solutions, such as polyethersulfone, are not rated for neat DMSO. The author had no such filter at hand.

The author's personal assessment is that this was sufficient in this case, because DMSO itself has antiseptic properties and the solution is mixed into bacteriostatic water, which contains a preservative. That is the author's own view, recorded as such.

The opposing position rests on the standards themselves. A Ph. Eur. grade certifies purity, not sterility. An antiseptic effect reduces some microbial populations but is not a validated sterilisation step, and it does nothing about spores or endotoxins. The benzyl alcohol in bacteriostatic water inhibits multiplication and does not sterilise either. In the documented pharmaceutical standard, a solution becomes sterile through a sterilising-grade 0.2 to 0.22 µm filter or a validated sterilisation process, not through the properties of its ingredients. This page records both positions and does not choose between them.

Concentration arithmetic

The maths afterwards is substance-independent. Concentration is the mass in the vial divided by the total final volume, cosolvent included, so in this run the 5 mg are spread across 3 mL of mixture, not across the 2.5 mL of water alone. The volume that contains a given amount is that amount divided by the concentration. The reconstitution calculator does the conversion as a unit converter, and what mg, mL and IU actually mean covers the units.

Regulatory status

SLU-PP-332 is not approved as a medicine in the United States, the European Union, Australia or elsewhere, and no human clinical safety or efficacy data are published. It is a research compound, and a research-use-only label is a commercial description rather than a regulatory category. Legal status varies by country – that question has its own page.

Common questions

Is SLU-PP-332 a peptide?

No. It is a synthetic small molecule described as a pan-agonist at the estrogen-related receptors, and its identifier comes from a laboratory compound series rather than an amino-acid sequence. It behaves like a poorly water-soluble organic solid.

Can SLU-PP-332 be dissolved in bacteriostatic water alone?

Not to any useful extent. The compound is largely non-polar, so water offers it no favourable interactions, and the benzyl alcohol in bacteriostatic water is a preservative at about 0.9%, far too dilute to act as a cosolvent. Patience or an ultrasonic bath only produce a suspension that settles out again.

Why is the DMSO solution added to the water and not the other way round?

When a small volume of DMSO solution enters a larger, moving volume of water, only small pockets pass through the intermediate compositions, and they are diluted within moments. Adding water to the DMSO solution instead drives the whole solution through a gradually falling cosolvent fraction, and wherever the dissolved amount exceeds what that mixture can hold, the compound precipitates.

Is Ph. Eur. DMSO sterile?

No. A pharmacopoeial grade such as Ph. Eur. sets limits for purity, related substances and water content; it says nothing about sterility unless a product is separately manufactured and labelled as sterile. The documented standard for making a solvent-based solution sterile is filtration through a 0.22 µm membrane that is compatible with the solvent, such as PTFE.

What do streaks in the vial mean?

Streaks, also called schlieren, are zones of different refractive index where the DMSO solution and the water have not yet mixed. They are a mixing phenomenon, not a sign of precipitation, and they disappear once the liquid is swirled to a uniform composition. Cloudiness or visible particles that persist are a different matter and indicate solid out of solution.

Why was the DMSO handled quickly?

DMSO is a strong solvent for many plastics and can dissolve the lubricating coating on the inside of a plastic syringe barrel. The shorter the contact time between neat DMSO and the syringe, the less material is extracted into the liquid, which is why the author kept each transfer brisk without rushing it.

Does an ultrasonic bath change anything?

Sonication changes how fast a dissolution happens, not whether it can happen at all. It breaks up agglomerates and refreshes the liquid layer around each particle, but equilibrium solubility stays where it was.

Is SLU-PP-332 an approved medicine?

No. It has no marketing authorisation in any major jurisdiction and no published human clinical safety or efficacy data. A research-use-only label carries no regulatory assurance of identity, purity or sterility.

Sources

1. Billon C, Sitaula S, Banerjee S, et al. Synthetic ERRα/β/γ agonist induces an ERRα-dependent acute aerobic exercise response and enhances exercise capacity. ACS Chemical Biology 2023;18(4):756–771. doi:10.1021/acschembio.2c00720. Preclinical mouse data; no human data. PubMed 36988910
2. Yalkowsky SH. Solubility and Solubilization in Aqueous Media. American Chemical Society / Oxford University Press, 1999. Log-linear cosolvency model.
3. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharmaceutical Research 2004;21(2):201–230. PubMed 15032302
4. USP-NF monograph "Dimethyl Sulfoxide"; European Pharmacopoeia monograph "Dimethyl sulfoxide" (Dimethylis sulfoxidum). Purity and water-content limits for pharmacopoeial grades.
5. USP General Chapter 797, Pharmaceutical Compounding — Sterile Preparations. Aseptic technique and closure disinfection. usp.org
6. U.S. Food and Drug Administration. Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice. September 2004. Sterilising filters with a rated pore size of 0.2 µm or smaller; 0.22 and 0.2 µm treated as interchangeable nominal ratings. fda.gov

General, neutral information about the chemistry of a research compound and a description of one documented run – not medical advice, not a dosing or usage recommendation, and not an invitation to obtain any substance. SLU-PP-332 holds no marketing authorisation, and whether possession and use are lawful depends on the law of your country of residence. Health questions belong with a qualified physician or pharmacist.